{"title": "Diagnosis and treatment of orthostatic hypotension in Parkinson's disease", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2023-09-20", "cleaned_text": "A\u00f1o de publicaci\u00f3n - 2013 - Idioma - ingl\u00e9s - Tipo de recurso - art\u00edculo - Estado - versi\u00f3n publicada - Descripci\u00f3n - Fil: P\u00e9rez Lloret, Santiago. Pontificia Universidad Cat\u00f3lica Argentina. Laboratorio de Farmacolog\u00eda Cl\u00ednica y Epidemiolog\u00eda; Argentina Fil: P\u00e9rez Lloret, Santiago. Universidad de Toulouse III. Hospital Universitario. Departamento de Investigaci\u00f3n Cl\u00ednica; Francia Fil: P\u00e9rez Lloret, Santiago. Universidad de Toulouse III. Hospital Universitario. Departamento de Farmacolog\u00eda Cl\u00ednica y Neurociencias; Francia Fil: P\u00e9rez Lloret, Santiago. Institut national de la sant\u00e9 et de la recherche m\u00e9dicale; Francia Fil: Rey, Ver\u00f3nica. Pontificia Universidad Cat\u00f3lica Argentina. Laboratorio de Farmacolog\u00eda Cl\u00ednica y Epidemiolog\u00eda; Argentina Fil: Rey, Ver\u00f3nica. Universidad de Toulouse III. Hospital Universitario. Departamento de Investigaci\u00f3n Cl\u00ednica; Francia Fil: Rey, Ver\u00f3nica. Universidad de Toulouse III. Hospital Universitario. Departamento de Farmacolog\u00eda Cl\u00ednica y Neurociencias; Francia Fil: Rey, Ver\u00f3nica. Institut national de la sant\u00e9 et de la recherche m\u00e9dicale; Francia Fil: Pavy-Le Traon, Anne. Universidad de Toulouse III. Hospital Universitario. Departamento de Investigaci\u00f3n Cl\u00ednica; Francia Fil: Pavy-Le Traon, Anne. Universidad de Toulouse III. Hospital Universitario. Departamento de Farmacolog\u00eda Cl\u00ednica y Neurociencias; Francia Fil: Pavy-Le Traon, Anne. Institut national de la et de la recherche m\u00e9dicale; Francia Abstract: Orthostatic hypotension (OH) is a faster cognitive decline and connected to increased mortality. OH can be arbitrarily defined as a drop of systolic and/or diastolic blood pressure of 20 or 10 mmHg or more in the first three minutes after passing from decubitus to an upright position. Till test appears to be the most reliable tool for assessing the orthostatic response. On the other hand, the standing test and evaluation of orthostatic symptoms should be regarded as screening tests. OH is an frequently used treatments, even though evidence about their efficacy and safety is weak. Midodrine has a shorter duration of action and thus avoidance of evening dosing may help keep nocturnal blood dipping intact. Promising alternatives may include droxidopa and fipamezole - Fuente - Journal of Integrative Medicine, Vol. 1, Nro. 27, 2013 - Materia - ENFERMEDADES NEUROGENERATIVAS ENFERMEDAD DE PARKINSON TRATAMIENTO HIPOTENSION ORTOSTATICA - Nivel de accesibilidad - acceso abierto - Condiciones de uso - https://creativecommons.org/licenses/by-nc-sa/4.0/ - Repositorio - Instituci\u00f3n - Pontificia Universidad Cat\u00f3lica Argentina - OAI Identificador - oai:ucacris:123456789/1640 [Ver los metadatos Santiago. Pontificia Universidad Cat\u00f3lica Argentina. Laboratorio de Farmacolog\u00eda Cl\u00ednica y Epidemiolog\u00eda; ArgentinaFil: P\u00e9rez Lloret, Santiago. Universidad de Toulouse III. Hospital Universitario. Departamento de Investigaci\u00f3n Cl\u00ednica; FranciaFil: P\u00e9rez Lloret, Santiago. Universidad de Toulouse III. Hospital Universitario. Departamento de Farmacolog\u00eda Cl\u00ednica y Neurociencias; FranciaFil: P\u00e9rez Lloret, Santiago. Institut national de la sant\u00e9 et de la recherche m\u00e9dicale; FranciaFil: Rey, Ver\u00f3nica. Pontificia Universidad Cat\u00f3lica Argentina. Laboratorio de Farmacolog\u00eda Cl\u00ednica y Epidemiolog\u00eda; ArgentinaFil: Rey, Ver\u00f3nica. Universidad de Toulouse III. Hospital Universitario. Departamento de Investigaci\u00f3n Cl\u00ednica; FranciaFil: Rey, Ver\u00f3nica. Universidad de Toulouse III. Hospital Universitario. Departamento de Farmacolog\u00eda Cl\u00ednica y Neurociencias; FranciaFil: Rey, Ver\u00f3nica. Institut national de sant\u00e9 et de la recherche m\u00e9dicale; FranciaFil: Pavy-Le Traon, Anne. Universidad de Toulouse III. Hospital Universitario. Departamento de Investigaci\u00f3n Cl\u00ednica; FranciaFil: Pavy-Le Traon, Anne. Universidad de Toulouse III. Hospital Departamento de Farmacolog\u00eda Cl\u00ednica y Neurociencias; FranciaFil: Pavy-Le Traon, Anne. Institut national de la recherche m\u00e9dicale; FranciaAbstract: Orthostatic hypotension (OH) is a faster cognitive decline and connected to increased mortality. OH can be arbitrarily defined as a drop of systolic and/or diastolic blood pressure of 20 or 10 mmHg or more in the first three minutes after passing from decubitus to an upright position. Till test appears to be the most reliable tool for assessing the orthostatic response. On the other hand, the standing test and evaluation of orthostatic symptoms should be regarded as screening tests. OH is an frequently used treatments, even though evidence about their efficacy and safety is weak. Midodrine has a shorter duration of action and thus avoidance of evening dosing may help keep nocturnal blood dipping intact. Promising alternatives may [en doi: 10.5772/56924. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/1640Journal of Integrative Medicine, Vol. Diagnosis and Parkinson's disease | P\u00e9rez Lloret, Santiago ENFERMEDAD DE PARKINSON TRATAMIENTO HIPOTENSION ORTOSTATICA Ver\u00f3nica Pavy-Le Traon, Anne Rascol, Olivier |author|| P\u00e9rez Lloret, Santiago |author_facet|| P\u00e9rez Lloret, Santiago | Rey, Ver\u00f3nica Pavy-Le TRATAMIENTO HIPOTENSION ORTOSTATICA |topic|| ENFERMEDADES | ENFERMEDAD DE PARKINSON TRATAMIENTO HIPOTENSION ORTOSTATICA |dc.description.none.fl_txt_mv|| Fil: P\u00e9rez Lloret, Santiago. Pontificia Universidad Cat\u00f3lica Argentina. Laboratorio de Farmacolog\u00eda Cl\u00ednica y Epidemiolog\u00eda; Argentina | Fil: P\u00e9rez Lloret, Santiago. Universidad de Toulouse III. Hospital Universitario. Departamento de Investigaci\u00f3n Cl\u00ednica; Francia Fil: P\u00e9rez Lloret, Santiago. Universidad de Toulouse III. Hospital Universitario. Departamento de Farmacolog\u00eda Cl\u00ednica y Neurociencias; Francia Fil: P\u00e9rez Lloret, Santiago. Institut national de la sant\u00e9 et de la recherche m\u00e9dicale; Francia Fil: Rey, Ver\u00f3nica. Pontificia Universidad Cat\u00f3lica Argentina. Laboratorio de Farmacolog\u00eda Cl\u00ednica y Epidemiolog\u00eda; Argentina Fil: Rey, Ver\u00f3nica. Universidad de Toulouse III. Hospital Universitario. Departamento de Investigaci\u00f3n Cl\u00ednica; Francia Fil: Rey, Ver\u00f3nica. Universidad de Toulouse III. Hospital Universitario. Departamento de Farmacolog\u00eda Cl\u00ednica y Neurociencias; Francia Fil: Rey, Ver\u00f3nica. Institut national de la sant\u00e9 et de la recherche m\u00e9dicale; Francia Fil: Pavy-Le Traon, Anne. Universidad de Toulouse III. Hospital Universitario. Departamento de Investigaci\u00f3n Cl\u00ednica; Francia Fil: Pavy-Le Traon, Anne. Universidad de Toulouse III. Hospital Universitario. Departamento de Farmacolog\u00eda Cl\u00ednica y Neurociencias; Francia Fil: Pavy-Le Traon, Anne. Institut national de la et de la recherche m\u00e9dicale; Francia Abstract: Orthostatic hypotension (OH) is a faster cognitive decline and connected to increased mortality. OH can be arbitrarily defined as a drop of systolic and/or diastolic blood pressure of 20 or 10 mmHg or more in the first three minutes after passing from decubitus to an upright position. Till test appears to be the most reliable tool for assessing the orthostatic response. On the other hand, the standing test and evaluation of orthostatic symptoms should be regarded as screening tests. OH is an frequently used treatments, even though evidence about their efficacy and safety is weak. Midodrine has a shorter duration of action and thus avoidance of evening dosing may help keep nocturnal blood may include droxidopa and fipamezole |description|| Fil: P\u00e9rez Lloret, Santiago. Pontificia Universidad Cat\u00f3lica Argentina. Laboratorio de Farmacolog\u00eda Cl\u00ednica y Epidemiolog\u00eda; Argentina | |publishDate|| 2013 [en [en 10.5772/56924. Disponible en: |dc.source.none.fl_str_mv|| Journal of Integrative Medicine, Vol. 1, Nro. 27, 2013 | reponame:Repositorio Institucional (UCA) instname:Pontificia Universidad Cat\u00f3lica Argentina instacron:UCA |reponame_str|| Repositorio Institucional (UCA) | |collection|| Repositorio Institucional (UCA) | |instname_str|| Pontificia Universidad Cat\u00f3lica Argentina | |instacron_str|| UCA | |institution|| UCA | |repository.name.fl_str_mv|| Repositorio Institucional (UCA) - Pontificia Universidad Cat\u00f3lica Argentina | |repository.mail.fl_str_mv|| claudia_fernandez@uca.edu.ar | |_version_|| 1777569963326832640 | |score|| 12.888536 | "}